Healthcare -
Biotechnology - NASDAQ - US
$ 36.18
1.12 %
$ 3.37 B
Market Cap
-9.8
P/E
Price Target
Average
99.79%
Revenue Forecast
Estimate
405.13%
EBIT
Estimate
--32.45%
Net Income
Estimate
49.85%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Crinetics Pharmaceuticals, Inc.
Wall Street analysts predict an average 1-year price target for CRNX of $72.3 , with forecasts ranging from
a
low of
$54 to a high of $97 .
CRNX Lowest Price Target
Wall Street Target
54 USD
49.25%
CRNX Average Price Target
Wall Street Target
72.3 USD
99.79%
CRNX Highest Price Target
Wall Street Target
97 USD
168.10%
REVENUE FORECAST
Revenue Forecast Chart CRNX
EBIT FORECAST
EBIT Forecast Chart CRNX
NET INCOME FORECAST
Net Income Chart CRNX